Cardioprotective glucose-lowering drugs, statins, and secondary major adverse cardiovascular events: a nationwide cohort study of individuals with type 2 diabetes and cardiovascular disease. [PDF]
Ternhamar T +3 more
europepmc +1 more source
Glucagon-like Peptide-1 Receptor Agonists and Risk of Tuberculosis in Type 2 Diabetes. [PDF]
Liao KM, Wu JY, Lai CC.
europepmc +1 more source
Dipeptidyl peptidase-4 inhibitors suppress myofibroblastic differentiation and hyaluronan synthesis in Graves' orbitopathy fibroblasts. [PDF]
Shih CW +7 more
europepmc +1 more source
Lower Risk of Incident Dementia with SGLT2 Inhibitor Versus DPP-4 Inhibitor Initiation in Patients with Type 2 Diabetes and Prior Traumatic Brain Injury: A Retrospective Cohort Study. [PDF]
Hung KC, Weng HL, Chen IW.
europepmc +1 more source
Glycemic Outcomes After Switching from SGLT2 Inhibitors to DPP-4 Inhibitors in Type 2 Diabetes, with a Comparison of Teneligliptin and Other Agents: A Retrospective Cohort Study. [PDF]
Lim JY +6 more
europepmc +1 more source
Antidiabetic medications and risk of cognitive disorders in type 2 diabetes: A retrospective cohort study. [PDF]
Nasir AB +11 more
europepmc +1 more source
Circular Valorization of Yellowfin Tuna (<i>Thunnus albacares</i>) Bone By-Products into Bioactive Hydrolysates Using Endogenous Visceral Proteases Compared with Commercial Trypsin. [PDF]
Encalada B +7 more
europepmc +1 more source
Dipeptidyl Peptidase-4 Inhibitor Use and Risk of Major Adverse Cardiovascular Events in Patients with COPD and Diabetes: A Nationwide Retrospective Cohort Study. [PDF]
Ho CH, Shao YC, Wu YC, Liao KM.
europepmc +1 more source
Effectiveness of Metformin in Preventing Colorectal Cancer Among Japanese Patients With Type 2 Diabetes: A Target Trial Emulation. [PDF]
Hiroki S +3 more
europepmc +1 more source

